Since OurCrowd was founded over a decade ago, it has been a leading investor in early-stage startups. While OurCrowd has funded many seed-stage companies, there has been a clear effort to back incubators which nurture a plethora of startups across many sectors. Today, OurCrowd is the leading investor in Israeli incubators and has expanded to the international incubator market. 

OurCrowd currently co-owns six incubators, five in Israel and one in New Zealand, which have a combined number of 70 portfolio companies operating in an array of sectors. Each incubator portfolio company receives up to 75%-85% in non-dilutive government funding, in the form of a “conditional loan” with the government not receiving any equity. The incubator model can provide a distinct financial advantage to external investors as a company graduates and continues to grow. Co-investors and partners in the incubators include Finistere, Fonterra, Hadasit, Reliance, Padagis, Technion, Tempo and Tnuva. 

For the first time, OurCrowd is offering all its investors an opportunity to claim a stake in its existing and future incubator portfolio.  Hear more about this exciting opportunity at this exclusive virtual event. You MUST sign the NDA in order to attend.

Speakers:

Jon Medved, Founder & CEO, OurCrowd

Zohar Gendler, Managing Partner & CEO, NGT Healthcare II

Noga Sela Shalev, CEO, FreshStart

Moderator: Ori Sobovitz, Partner, Government Relations and Israeli Partnerships, OurCrowd